Point of Care Diagnostics Market Study for 2022 to 2028 Providing Information on Growth Drivers, and Industry Analysis
Global Point of Care Diagnostics Market was valued at USD 30.30 billion in 2021 and is expected to reach USD 53.98 billion by the year 2028, at a CAGR of 8.6%.
Point of care testing (POCT) is critical for detecting analytes close to the patient, allowing for better disease diagnosis, monitoring, and management. It allows for quick medical decisions because diseases can be diagnosed at an early stage, resulting in better health outcomes for patients by allowing for the early start of treatment. POC testing was first used in 1962 with the development of a method for rapid analysis of blood glucose, and soon after, in 1977, rapid pregnancy tests were developed, ushering in a trend for personalized diagnostics. POC diagnostic devices for monitoring glucose, ECG, blood pressure, and other parameters have greatly aided clinical and personalized healthcare. Several prospective POCDs have been developed in recent years, providing a platform for next generation POCT. The biosensor is the most important component of POCD and is directly responsible for an assay's bioanalytical performance.
The research study includes an examination of many aspects that contribute to the market's expansion. Market trends, restrictions, and drivers that have a favorable or negative influence on the market are included. This section also discusses the many businesses and applications that may have an impact on the market in the future. The information is based on both recent and historical patterns. The cost structure, market size, Point of Care Diagnostics Sales, Gross Margin and Market Share, Price, Revenue, Size, Forecast, and Growth Rate are all calculated in the report.
To learn more about this report, request a free sample copy: https://introspectivemarketresearch.com/request/16302
Key Industry Players in the Point of Care Diagnostics Market:
• F. Hoffmann La Roche Ltd (Basel, Switzerland)
• Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
• Abbott Laboratories (Illinois, U.S.)
• Quest Diagnostics Incorporated (New Jersey, U.S.)
• BD (Franklin Lakes, U.S.)
• BioMerieux SA (Marcy l'Etoile, France)
• Cardinal Health, Inc. (Ohio, U.S.)
• Mesa Biotech (California, U.S.)
• Cepheid (California, U.S.)
• Trinity Biotech (Bray, Ireland)
• Quidel Corporation (San Diego, U.S.)
• Bio Rad Laboratories Inc. (California, U.S.) and Other Major Players.
The global POC Diagnostics market is segmented on the basis of product, end user, mode of prescription, and region. By product, the point of care diagnostic kit market is segmented into glucose monitoring kit, infectious diseases testing kit, pregnancy, and fertility testing kit, hematology testing kit, cardiometabolic monitoring kit, urinalysis testing kit, cholesterol test strips, drug of abuse testing kit, and others. By end user, the global point of care
diagnostics market is segmented into professional diagnostic centers, research laboratories, homes, and others. By mode of prescription, the global point of care diagnostics market is segmented into prescription based point of care diagnostics and over the counter (OTC) based point of care diagnostics market. Segmentation
By
North America (U.S., Canada, Mexico) • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe) • Asia Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC) • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA) • South America (Brazil, Argentina, Rest of SA)
• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the POC Diagnostics Market Size analysis from 2020 to 2030 to identify the prevailing point of care diagnostics market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit oriented business decisions and strengthen their supplier buyer network.
• In depth analysis of the point of care diagnostics market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The recent outbreak of COVID 19 positively impacted the clinical laboratories segment, as the pandemic has boosted clinical laboratory testing services. Based on the study published by the National Center for Biotechnology Information in July 2020, the use of clinical diagnostics, including molecular and serological testing approaches for severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) testing, has increased. The increasing number of COVID 19 variants is further likely to drive the growth of the clinical laboratories segment.
Purchase This Report:
https://introspectivemarketresearch.com/checkout/?user=1&_sid=16302
Point of care diagnostics has witnessed considerable progress in the past years. Integration of molecular diagnostics in POC testing is one of the significant advancements in this segment. Despite the fact that major players have limited the opportunities for new entrants, some companies were able to mark their entry into the market.
Related Report:
https://introspectivemarketresearch.com/reports/liver cancer diagnostics market/ https://introspectivemarketresearch.com/reports/blood transfusion diagnostics market/ https://introspectivemarketresearch.com/reports/influenza diagnostics market/
We are a global market research company, specialized in using big data and advanced analytics with strategic consulting to help our clients get acclimatize with the future market trends. Our experts at IMR help our clients gain knowledge about the past and present market condition to gain a holistic idea about the future.
We are a technology driven research company with strategic analysis. We analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. Our core niches are performing regional demand and estimation and forecasting, Manufacturing and Product sourcing strategy, Competitive and Landscape Analysis, Cost Benefits, Demand Supply Analysis, Mergers and Acquisitions.
or More Information, please contact:
Email: sales@introspectivemarketresearch.com
US: +1 773 382 1047 INDIA: +91 81800 96367
US Office 3001 S King Drive, Chicago, Illionis 60616 USA Phone: 1 773 382 1047
Asia Pacific Office
Introspective Market Research, Office No. 101, Saudamini Commercial Complex, Chandani Chowk, Kothrud, Pune India 411038